# Lisata Therapeutics, Inc.: Form DEF 14A, filed Oct 19, 2026

- Company: [Lisata Therapeutics, Inc.](/companies/lsta.md) (CIK 320017)
- Form: DEF 14A
- Filed: 2026-10-19
- Accepted by EDGAR: Oct 19, 2026, 10:38 ET
- Period: 2026-11-09
- Accession: 0001140361-26-039986
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/320017/000114036126039986/ny20082391x2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/320017/000114036126039986/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/320017/000114036126039986/ny20082391x2_def14a.htm

Filed Oct 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-039986. Last ingested by Listed: Oct 24, 2026, 14:56 ET. No prices; not investment advice.